Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLAR: Abraxane, Oxaliplatin, and S-1/LV in advanced gastric, pancreatic, and biliary cancers
NCT03162510Phase 1Completed
- Sponsor
- National Health Research Institutes
- Start
- Jun 2018
- Primary completion
- Jun 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of nab-paclitaxel in gastric cancer (GC), pancreatic cancer (PC) and biliary cancer, sponsored by National Health Research Institutes. Started Jun 2018; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
gastric cancer (GC)pancreatic cancer (PC)biliary cancer
Beyond the preview
Go deeper on NCT03162510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03162510.